Mucormicosis asociada a COVID-19: revisión de la literatura para odontólogos / COVID-19 associated mucormycosis: a literature review for dentists

La mucormicosis es una infección fúngica rara, con alta morbilidad y mortalidad. Se presenta principalmente en pa- cientes con diabetes mellitus no controlada, inmunocompro- metidos, con tratamiento crónicos con esteroides, entre otros. Actualmente, se cree que la pandemia de COVID-19 y los tratamientos con corticosteroides podrían estar implicados en el aumento de casos de esta micosis. Este hongo invade el sistema vascular, ocluyendo el flujo sanguíneo arterial y generando una rápida trombosis e isque- mia, lo que provoca la necrosis de los tejidos duros y blandos, con invasión rápida a los tejidos circundantes. Hay varias formas clínicas. En la cavidad bucal se presenta la variante rino-orbito-cerebral, que afecta el paladar en forma de lesión eritematosa o grisácea que puede progresar hacia la formación de una masa necrótica o ulceración con muy escaso sangrado de mucosa. Se manifiesta con síntomas típicos de una rinosinusitis con fiebre y dolor en las piezas dentarias superiores. El tratamiento consta de tres pilares fundamentales: el diagnóstico, un manejo adecuado de las comorbilidades y la combinación de las terapias antifúngica y quirúrgica. Desde el año 2020, la mucormicosis asociada a COVID-19 pasó a ser un evento de notificación obligatoria inmediata al Sistema Nacional de Vigilancia de la Salud (SNVS2.0) me- diante el Sistema Integrado de Información Sanitaria Argen- tina (SISA). Es importante destacar que se han reportado casos de mu- cormicosis luego de extracciones dentales; lo que impulsa a afianzar los conocimientos sobre esta enfermedad, extremar las medidas preventivas e incentivar el diagnóstico precoz en la atención odontológica, debido a la rapidez en la evolución de la patología (AU))

Mucormycosis is a rare fungal infection, with high mor- bidity and mortality. It occurs mainly in patients with uncon- trolled diabetes mellitus, immunocompromised, on chronic treatment with steroids, among others. Currently, it is believed that the COVID-19 pandemic and the corticosteroid treatments could be one of the causes of increased cases. This fungus invades the vascular system, occluding arteri- al blood flow and generating rapid thrombosis and ischemia, which causes necrosis of hard and soft tissues, with rapid in- vasion to the surrounding tissues. There are several clinical forms. In the oral cavity, the rhino-orbito-cerebral variant presents itself affecting the pal- ate in the form of an erythematous or grayish lesion that can progress towards the formation of a necrotic mass or ulcera- tion with very little mucosal bleeding. It manifests itself with typical symptoms of rhinosinusitis, with fever and pain in the upper teeth. The treatment consists of three fundamental pillars: diag- nosis, proper management of comorbidities and the combina- tion of antifungal and surgical therapies. Since 2020, COVID-19 associated mucormycosis became an event of mandatory immediate notification to the National Health Surveillance System (SNVS2.0,) through the Argentina Integrated Health Information System (SISA). It is important to emphasize that mucormycosis cases had been reported following tooth extractions, which drives to strengthen knowledge about this disease, extreme preventive measures and encourage early diagnosis in dental care, due to the speed of the evolution of the pathology (AU))

Clinical features of children with Cunninghamella spp. infection: a case report and literature review / 南方医科大学学报

We report a case of mucormycosis induced by Cunninghamella spp. infection in a ten-year-old girl with acute lymphoblastic leukemia, who developed fever and respiratory symptoms after chemotherapy and was diagnosed with invasive fungal disease. Peripheral blood DNA sequences were analyzed using metagenomic next-generation sequencing (mNGS), and by comparison with the Pathogens Metagenomics Database (PMDB), we identified Cunninghamella spp. with sequence number 514 as the pathogen. The patient was treated with amphotericin B combined with posaconazole and showed a favorable response. We searched Pubmed, Embase, CNKI, and Wanfang database for reports of cases of Cunninghamella spp. infection in children and retrieved 22 reported cases (including 12 males) with a median age of 13.5 (3-18) years. In these 22 cases, hematological malignancy was the most common underlying condition (19/22), and most of patients experienced an acute onset and rapid progression with respiratory symptoms (14/20) and fever (16/20) as the most common symptoms. CT imaging often showed unilateral lesions with varying imaging findings, including pulmonary nodules or masses, infiltrative changes, and pleural effusion. Definite diagnoses were established in 18 of the cases, and 4 had probable diagnoses; the lungs and skin were the most frequent organs compromised by the infection. A definite diagnosis of Cunninghamella spp. infection still relied on histopathological examination and fungal culture, but the molecular techniques including PCR and mNGS had shown potentials in the diagnosis. Almost all the cases received antifungal treatment after diagnosis (21/22), and 13 patients also underwent surgeries. Death occurred in 9 (42%) of the cases at a median of 19 (4-54) days after onset of the signs or symptoms. The patients receiving antifungal therapy combined with surgery had a high survival rate (9/13, 69%) than those with antifungal therapy alone (3/8, 37%). Invasive fungal disease is a common complication in immunoco-mpromised patients, but Cunninghamella spp. infection is rare and has a high mortality rate. In cases highly suspected of this disease, active diagnosis and early treatment are critical to improve the survival outcomes of the patients.

Cutaneous mucormycosis of scalp and eyelids in a child with type I diabetes mellitus.

Scalp mucormycosis in children is extremely rare. We present a case of pediatric scalp mucormycosis caused by Rhizopus oryzae in a 9-year-old diabetic girl who was successfully diagnosed and treated with amphotericin B deoxycholate and wound debridement. At 3 months follow up, the patient was stable although she had lost her vision.

El Subphylum Mucoromycotina: generalidades y aspectostaxonómicos recientes / Mucoromycotina Subphylum: overview and recent taxonomic aspects

El subphylum Mucoromycotina es un grupo de hongos ubicuos, saprobios, caracterizados por la presencia de hifas cenocíticas. También se caracterizan por presentar una fase sexual con la formación de una zigospora. Los mucormycetes son capaces de infectar plantas, animales y seres humanos. Recientemente, varios estudios han comunicado de la creciente incidencia de mucormicosis en pacientes inmunocomprometidos e inmunocompetentes. Dados los avances en biología molecular, la sistemática de este grupo de hongos ha experimentado varios cambios taxonómicos en los últimos años. Este artículo discutirá los principales cambios taxonómicos, en especial de los géneros y especies de interés clínico.

The subphylum Mucoromycotina is a group of fungi with several ubiquitous, and saprotrophic species which are characterized by the presence of coenocytic hyphae. Also have a sexual phase characterized by the formation of zygospores. The mucormycetes are able to infect plants, animals and humans. Recently, several studies have reported the increasing incidence of mucormycosis in both immunocompromised and immunocompetent patients. Given the advances in molecular biology, the systematic of this group of fungi has experimented several taxonomical changes. This paper will discuss the major taxonomic changes, particularly of those genera and species of clinical interest.

Mucormicosis en una paciente diabética: caso clínico y revisión de la literatura / Mucormycosis in a diabetic patient: case report and literature review

Presentamos un caso de Mucormicosis Rinoorbitaria en una mujer de 48 años, diabética, en cetoacidosis, a quien se hizo el diagnóstico por histopatología. Tratada con anfotericina B intravenosa y un agresivo debridamiento quirúrgico para eliminar tejidos infartados y necróticos de gran parte de la hemicara y ojo derecho, logra sobrevivir a esta catastrófica infección. La mucormicosis es una infección aguda y extremadamente grave causada por hongos oportunistas y ubicuos del orden Mucoroles pertenecientes a la clase Phycomycetes, que afecta principalmente a un grupo de pacientes cuyas condiciones inmunológicas y metabólicas favorecen el desarrollo del hongo. Hacemos una definición del grupo de "pacientes en riesgo", lo que es extremadamente importante, ya que de la sospecha clínica se puede abordar un diagnóstico precoz para evitar la alta mortalidad y morbilidad que esta enfermedad provoca. Analizamos la patogenia de la enfermedad, así como una revisión de la literatura sobre modalidades de diagnóstico y terapéutica. El diagnóstico de urgencia sigue siendo de responsabilidad del patólogo, y el tratamiento de mayor éxito es la anfotericina B.

We present a case of rhinoorbital mucormycosis in a diabetic, developing ketoacidose, 48-year old woman. Diagnosis was established through histopathology. The patient was successfully treated and survives with a combination of anphotericin B and an aggressive surgery in order to eliminate all the ischemic and necrotic tissues affecting almost the entire right side of the face and intraorbital structures surviving to this catastrophic infection. Mucormycosis is an acute and often fatal infection caused by opportunistic fungus of the class Zygomycetes, order Mucoroles that affects a select group of patients associated with underlying metabolic and immunological disorders. A definition of "risk-group" is proposed. This definition is of extreme importance for a prompt diagnosis avoiding the high rate of morbidity and mortality associated with this condition. We review both pathogenic mechanism and literature related to diagnostic modalities and new therapeutical approaches. Emergency diagnosis is still in hands of pathologists and the most successful treatment is with anphotericin B.

Mucormicose: estudo clínico / Mucormycosis: clinical study

A mucormicose é uma infecção fúngica oportunista, habitualmente fulminante, que acomete, principalmente, imunodeprimidos. Pode apresentar-se sob as formas rinocerebral, pulmonar, gastrintestinal, cerebral, cutânea, subcutânea e disseminada. O diagnóstico é estabelecido a partir da biopsia de tecido com envio de material para cultura de fungos, podendo-se usar exames de imagem para quantificar a área acometida. O tratamento é cirúrgico, devendo ser associado à anfotericina B.

Murcomicosis is a fungal opportunistic infection that is usually fatal, which attacks, essentially, immunodeficient people. It usually presents itself in: rinocerebral, pulmonary, gastrointestinal, cerebral, cutaneous, subcutaneous and disseminated forms. The diagnosis is established by tissue biopsy after fungal culture, and image exams. Can be used to calculate the surgical treatment should be associated with anfotericin B.

Primary cutaneous mucormycosis (zygomycosis) caused by Apophysomyces elegans.

A 53 year-old male diabetic presented with a month-old, painful ulcer with necrotic margins over the right thigh. Wound debridement was done twice and the ulcer showed recurrent growth of a white, cottony filamentous structure. Cutaneous mucormycosis was suspected and confirmed by histopathology and a culture isolate of Apophysomyces elegans . The patient was treated with liposomal amphotericin-B and itraconazole followed by partial thickness skin grafting, and then discharged after being prescribed posaconazole syrup for three weeks. Regular follow-up was done and during the last visit after six months following discharge, the ulcer was found to have healed well with no recurrence of the fungus.

Mucormicosis rino-orbito-cerebral: experiencia en doce años / Rhino-orbital-cerebral mucormycosis: a twelve-year experience

Introducción: La mucormicosis rino-órbito-cerebral (MROC) es una infección poco frecuente y de alta mortalidad, causada por hongos pertenecientes al orden Mucorales. Afecta excepcionalmente a individuos sanos, siendo mucho más frecuente que se produzca en sujetos inmunodeprimidos. Objetivo: Presentar la casuística de 12 años en mucormicosis del Hospital Barros Luco Trudeau. Material y método: El estudio incluye a 16 pacientes con MROC atendidos en el Hospital Barros Luco Trudeau, entre los años 1993 y 2004, detallando características clínicas de presentación de la enfermedad, procedimientos diagnósticos y terapéuticos realizados, efectos adversos de la terapia y mortalidad. Resultados: Sólo un paciente de la serie era inmunocompetente. El síntoma más frecuente fue dolor facial y el hallazgo más frecuente al examen físico, fue la presencia de una escara negra o grisácea en la mucosa nasal. El estudio micológico directo fue positivo en 11 casos, mientras que el cultivo de hongos resultó positivo sólo en 10 pacientes. Del total de pacientes, 15 recibieron tratamiento combinado de cirugía y terapia antifúngica intravenosa (anfotericina B). Once pacientes fueron debridados por medio de una cirugía abierta (8 maxilectomías parciales y 3 totales). Cuatro pacientes fueron debridados mediante una técnica endoscópicay todos ellos necesitaron mßs de un procedimiento. Discusión y Conclusión: Se discuten las causas y el hallazgo más consistente al examen físico y la conducta del hospital ante los casos sospechosos. También se comenta la importancia de las imágenes, el compromiso orbitario, la invasión cutánea y especialmente el tratamiento médico y quirúrgico. Se destaca la sobrevida general de la serie que fue de 62,5 por ciento

Introduction: Rhino-orbital-cerebral mucormycosis (MROC) is a rare, high mortality infection, produced by fungi belonging to the order Mucorales. It exceptionally affects healthy individuals, being much more prevalent in immunocompromised patients. Aim: To present the 12year experience in mucormycosis at the Barros Luco Trudeau Hospital. Material and Method: This study involves 16 MROC patients that were treatedatthe Barros Luco Trudeau Hospital between 1993 and 2004. We present detailed clinical characteristics of the disease, diagnostic and therapeutic procedures performed, adverse therapy effects and mortality. Results: Only one of the patients was immunocompetent. The most frequent symptom was facial pain and the most frequent finding at physical examination was a black or grayish scab on the nasal mucosa. Direct mycological study was positive in 11 cases, whereas fungal culture was positive in only 10 patients. Of all patients, 15 received combined surgical and intravenous antifungal therapy (amphotericin B). Eleven patients had debridement by open surgery (8 partial and 3 total maxillectomies). Four patients had endoscopic debridement; all of them required more than one procedure. Discussion and Conclusion: Possible causes are discussed as well as the more consistent findings at physical examination and the institution behavior when suspecting a case. In addition, imaging importance, orbital involvement, cutaneous invasion and medical and surgical treatments are discussed. The series survival rate of 62 percent is underscored

Mucormicosis de la pared abdominal: informe de un caso / Abdominal wall infection due to Mucormycosis: case report

Zygomycosis are infections due to fungus from the Zygomycetes family, and one of them is Mucor. They are a rare opportunist species that may cause severe invasive and often fatal infections. This infection has a special predilection for diabetic patients, transplant patients and those undergoing intensive cancer therapies, as well as other patients with an immunocompromised condition. Rapid diagnosis and opportune and current treatment is the key for patient surveillance. The most frequent site of this infection is the upper respiratory tract due to spore transport by air, although there are other sites in which these organisms can produce infection such as soft tissue of the abdominal wall. In this study, we present an abdominal wall infection by Mucor and describe its medical and surgical treatment.

Mucormicosis ocular / Ocular mucormycosis

La mucormicosis es una infección causada por hongos del orden de mucorales, esta entidad es poco frecuente y su aparición se relaciona con el estado inmune del paciente. Es muy importante sospecharla ante la presencia de una escara negra y realizar un diagnóstico precoz, tiene un pronóstico reservado. Las tasas de supervivencia se han ido incrementando de 6 hasta 73 por ciento y se vinculan con la extensión de la lesión al momento del diagnóstico y la gravedad del inmunocompromiso del paciente.

Mucormycosis is an infection caused by mucoral mushrooms; this illness is not very frequent and its occurence relates to the patient's immune state. It is very important to suspect about its existence whenever there is black eschar and to diagnose it early. Prognosis is conservative. Survival rates have increased from 6 to 73 percent and they are linked with lesion extension at the time of diagnosis and the immunosuppresive condition of the patient.

Mucormicosis rinosinusal en un paciente infectado por VIH / Rhinosinusal mucormicosis in an HIV positive patient

Mucormicosis es una infección fúngica oportunista producida por varias especies del orden Mucorales, como Rhizopus, Mucor, Cunninghamella y Absidia. Habitualmente se asocia con enfermedades oncohematológicas, diabetes mellitus, falla renal, tumores sólidos y trasplante de órganos sólidos o precursores hematopoyÚticos. Se presenta con una variedad de formas clÝnicas: rinocerebral, renal, pulmonar, cutßnea, gastrointestinal y diseminada. En pacientes infectados por VIH es poco frecuente. Presentamos una paciente atendida en el Hospital de Enfermedades Infecciosas Dr. Lucio Córdova, con infección por VIH en etapa C3 del CDC, CD4 < 100 cÚls/mm y tratamiento anti retroviral. La forma de presentación rinocerebral fue documentada por TAC que demostró la extensión de la lesión, y confirmada mediante biopsia y cultivo. Recibió anfotericina B mßs resección quirúrgica de todo el tejido necrótico. Completó 2.225 mg del antifúngico falleciendo un año y medio despuÚs, sin que se demostrara reactivación de la infección.

Fascitis necrosante por Apophysomyces elegans, moho de la familia mucoraceae, en paciente inmunocompetente / Necrotizing fasciitis in an immunocompetent patient caused by Apophysomyces elegans

Se presenta la historia de un niño de 7 años de edad, politraumatizado por accidente automovilístico, que falleció a consecuencia de infección por Apophysomyces elegans, un hongo de la familia Mucoracea. La invasión fue progresiva, inicialmente se observó una lesión puntiforme en la región lumbar izquierda que progresó a fascitis necrosante y, posteriormente, afectó la zona lumbar, los glúteos y el flanco derecho. El tratamiento antimicótico resultó inefectivo y el paciente falleció 8 semanas después de su accidente. Se presenta, además, una revisión de los casos atribuidos a este hongo

Mucormicosis rinocerebral: caso clínico / Rhinocerebral mucormycosis: clinical case

La mucormicosis es una enfermedad poco frecuente, causada por hongos del orden de los mucorales. Suele presentarse en pacientes con algún grado de inmunodepresión. La forma rinocerebral afecta principalmente a pacientes con cetoacidosis diabética. El cuadro clínico corresponde al de una sinusitis invasiva, con un curso generalmente fatal y el tratamiento es médico-quirúrgico. Se presenta un caso clínico con revisión de la literatura